A Very Different Look at COVID-19
InspectIR is the only testing methodology that does not create cross reactivity, which leads to pre-analytical error, based on adding a solvent or another reagent to bind to a specimen for analysis.
There is also no storage of any biologic material in the InspectIR test.
What makes us different:
Chemical-lab-in-a-box: we are analyzing breath via mass spectrometry.
InspectIR is the first company to make a commercially available miniature mass spectrometer to analyze breath samples directly
Leveraging Proven Science to Monitor Health & Wellness in a COVID-19 World
The COVID-19 pandemic has thrown our world into a state of unknown. Like many, InspectIR Systems asked “how can we help?” and began the necessary research.
InspectIR Systems was granted Emergency Use Authorization (EUA) on April 14th, 2022 after the successful completion of multiple clinical trials.
Contact InspectIR Systems, LLC
InspectIR is in rapid growth mode. Interested in learning more? Complete the form below & a member of our team will be in touch shortly,